Skip to content

Assessment of Augmented Reality in Minimally Invasive Surgery

Clinical Translation of Augmented Reality Visualization for Laparoscopic Surgery

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03678220
Enrollment
30
Registered
2018-09-19
Start date
2019-04-01
Completion date
2020-03-01
Last updated
2019-02-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Laparoscopic Hepatectomy, Laparoscopic Liver Thermal Ablation

Keywords

Laparoscopic Ultrasound

Brief summary

The objective of this study is to test the technical feasibility of LapAR visualization system for guiding laparoscopic surgeries and to gather clinical feedback on the use of this tool.

Detailed description

Surgeons use real-time video generated by a laparoscope to visualize the operative field when performing laparoscopic procedures. An inability to see beneath organ surfaces is a limitation of the current visualization technology. Surgeons additionally use laparoscopic ultrasound to see beneath organ surfaces, but also need to mentally correlate the ultrasound image with the video of the operative field. This process is difficult, subjective, and variable with expertise, and discourages the use of ultrasound. The investigators have developed a method to combine live laparoscopic video and laparoscopic ultrasound images to present fused multimodality images on a single display, eliminating the need for mental image correlation. Specifically, the image fusion method, called laparoscopic augmented reality (LapAR), augments the laparoscopic video with ultrasound data when required by surgeons. This study is designed to test this minimal-risk capability in patients referred for relevant laparoscopic procedures.

Interventions

DEVICELapAR

LapAR system will be used for guidance during laparoscopic hepatectomy and laparoscopic liver thermal ablation

Sponsors

National Institutes of Health (NIH)
CollaboratorNIH
National Cancer Institute (NCI)
CollaboratorNIH
University of Pittsburgh Medical Center
CollaboratorOTHER
IGI Technologies, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Patient is referred for either laparoscopic partial hepatectomy for tumor removal or laparoscopic ablation of liver cancer; 2. Patient must be at least 18 years old; 3. Patient provides written consent; 4. Patient is considered a suitable candidate based on tumor location for using the AR system.

Exclusion criteria

Patients with pacemaker or any other ICD(intra-cardiac device) which may interfere with electromagnetic tracking

Design outcomes

Primary

MeasureTime frameDescription
Surgeon interview regarding usabilitypost surgery, an expected average of 5 minutesThe ease of use of the LapAR system will be evaluated by the surgeon
Procedure timeduring surgeryTime of using the LapAR system for laparoscopic hepatectomy and laparoscopic thermal ablation
Measurement of marginpost surgeryObtain from Pathology department or follow-up imaging

Secondary

MeasureTime frame
System set-up timebefore surgery, an expected average of 15 min

Countries

United States

Contacts

Primary ContactRaj Shekhar, PhD
raj@igitechnologies.com202-476-1201
Backup ContactWilliam Plishker, PhD
will@igitechnologies.com202-713-9571

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026